Board approves Q2 results, divestment in AGL Proteins, Thailand unit investment
ASIANTILES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 2.2 pts less than its Ceramics peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q2 FY26 results: standalone revenue Rs 272.42 cr, net profit Rs 7.79 cr (EPS Rs 0.34). Consolidated revenue Rs 406.92 cr, net profit Rs 16.71 cr (EPS Rs 0.70). Also approved selling 25% stake in subsidiary AGL Proteins for Rs 25,000, reducing holding to 26% (becomes associate). Additional capital infusion approved in Thailand wholly owned subsidiary Harmony Surfaces for working capital and expansion.
Q2 results steady. Minor non-core subsidiary stake sale. Thailand capital infusion to support international expansion.